October 24, 2016 6:26 AM ET

Life Sciences Tools and Services

Company Overview of MetaMorphix, Inc.

Company Overview

MetaMorphix, Inc., a life sciences company, develops a pipeline of products and tests that addresses livestock sectors and enhances the health of companion animals. Its products engages in addressing various livestock sectors, including cattle, swine, poultry, and aquaculture; and engages in discovering and licensing targets to pharmaceutical companies that develop therapies for better management of metabolic and muscular degenerative diseases. MetaMorphix, Inc. was formerly known as Trophix, Inc. and changed its name to MetaMorphix, Inc. in June 1995. The company was founded in 1994 and is based in Beltsville, Maryland. It has a subsidiary location in Davis, California. As of March 18, 2011...

8000 Virginia Manor Road

Suite 140

Beltsville, MD 20705

United States

Founded in 1994

36 Employees





Key Executives for MetaMorphix, Inc.

Chief Financial Officer, Principal Accounting Officer, Executive Vice President and Treasurer
Age: 66
Chief of Operations and Executive Vice President
Age: 61
Vice President of Genomic Research and Development
Age: 60
Director of Software Development and Bioinformatics
Compensation as of Fiscal Year 2016.

MetaMorphix, Inc. Key Developments

SEC Orders Hearing On Registration Suspension Or Revocation Against MetaMorphix Inc. For Failure To Make Required Periodic Filings

Securities and Exchange Commission (SEC or the commission) instituted public administrative proceeding to determine whether to revoke or suspend for a period not exceeding twelve months the registration of each class of the securities of MetaMorphix Inc. for failure to make required periodic filings with the Commission. In this Order, the Division of Enforcement (Division) alleges that the company was delinquent in its required periodic filings with the Commission. In this proceeding, instituted pursuant to Exchange Act Section 12(j), a hearing will be scheduled before an Administrative Law Judge. At the hearing, the judge will hear evidence from the Division and the company to determine whether the allegations of the Division contained in the Order, which the Division alleges constitute failures to comply with Exchange Act Section 13(a) and Rules 13a-1 and 13a-13 there under, are true. The judge in the proceeding will then determine whether the registrations pursuant to Exchange Act Section 12 of each class of the securities of the company should be revoked or suspended for a period not exceeding twelve months. The Commission ordered that the Administrative Law Judge in this proceeding issue an initial decision not later than 120 days from the date of service of the order instituting proceeding.

Similar Private Companies By Industry

Company Name Region
10X Genomics, Inc. United States
4G Clinical, Inc. United States
AAPharmaSyn LLC United States
Abiant, Inc. United States
aBioBot, Inc. United States

Recent Private Companies Transactions

No transactions available in the past 12 months.

The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
Bertelsmann AG Europe
Bloomberg L.P. United States
NYC2012, Inc. United States
The Advertising Council, Inc. United States

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact MetaMorphix, Inc., please visit www.metamorphixinc.com. Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.